Form 4: CalciMedica Director Robert N. Wilson Acquires Stock Options
SEC Filing
Director Robert N. Wilson of CalciMedica, Inc. reports acquisition of stock options.
Summary
- Robert N. Wilson, a director of CalciMedica, Inc., filed a Form 4 with the SEC.
- The form reports the acquisition of stock options.
- On March 28, 2024, Wilson acquired options to purchase 10,000 shares of common stock at an exercise price of $4.16.
- The options vest monthly over one year, starting from the grant date.
- Following the transaction, Wilson directly owns options for 10,000 shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The acquisition of stock options by a director is generally viewed as a slightly positive signal, but it's a routine event.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of stock option grant |
| 03/27/2034 | Expiration date of the stock options |
| 04/22/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.